Home new

Accurate and non-invasive, our prognostic applications have the potential to fundamentally improve the treatment of disease

3-Dimensional Telomere Technology and Genomic Instability

Telomeres act as protective “caps” at the ends of chromosomes. Dysfunction or loss of telomeres can lead to chromosomal fusions leading to genomic instability and altering the normal behavior of cells, which may lead to the development of genetic diseases including cancer and neurodegenerative diseases

Telomeres act as protective “caps” at the ends of chromosomes. Dysfunction or loss of telomeres can lead to chromosomal fusions leading to genomic instability and altering the normal behavior of cells, which may lead to the development of genetic diseases including cancer and neurodegenerative diseases

Clinical Validation
TELO-MM test in development to address the Clinical Unmet Needs for Multiple Myeloma prognostics
TELO announced a clinical collaboration with Mayo Clinic to Validate Prognostic Applications for Multiple Myeloma to predict the transition of smoldering multiple myeloma patients to full stage myeloma, and to predict the relapse of myeloma patients while receiving first line therapy

Contact Us

info@telodx.com

Ph : 416-673-8487

Address

MaRS Centre, South Tower
101 College Street, Suite 200
Toronto, Ontario
Canada M5G 1L7

Contact Us

info@telodx.com
Ph : 416-673-8487

Address

MaRS Centre, South Tower
101 College Street, Suite 200
Toronto, Ontario
Canada M5G 1L7

(c) 2020 Telo Genomics . All rights reserved.

Website Designed & Maintained By :: WebStudio.ca